Patients with oligometastatic disease (OMD) often have controllable symptoms, and cures
are possible. Technical improvements in surgery and radiotherapy have introduced the …

Prostate cancer is the second most common cancer in men worldwide, with a wide spectrum
of biologic behavior ranging from indolent low-risk disease to highly aggressive castration …

Background In advanced prostate cancer (APC), successful drug development as well as
advances in imaging and molecular characterisation have resulted in multiple areas where …

99m Tc-MDP whole-body bone scintigraphy is a highly sensitive imaging method that has
been used for decades to evaluate prostate cancer bone metastasis based on its availability …

Numerous imaging modalities may be used for the staging of women with advanced breast
cancer. Although bone scintigraphy and multiplanar-CT are the most frequently used tests …

The term “oligometastatic prostate cancer” refers to a heterogeneous group of disease states
currently defined solely on the basis of clinical features. Oligorecurrent disease, de novo …

Purpose This meta-analysis aims to establish the diagnostic performance of 18 F-NaF-
PET/CT for the detection of bone metastases in prostate cancer patients. The performance of …

Purpose To provide an organized, international, state-of-the-art, and multidisciplinary
guideline, led by experts of two nuclear medicine societies (EANM and SNMMI) and …

(Aim) In order to detect pathological brains in a more efficient way,(Method) we proposed a
novel system of pathological brain detection (PBD) that combined wavelet packet Tsallis …

Purpose: Bone scintigraphy is the standard of reference in bone metastases in prostate
cancer patients. However, new radiotracers employed in prostate-specific membrane …